| Revenue, net | 0 |
| Cost of goods sold | 0 |
| Gross profit (loss) | 0 |
| Research and development | 979.42K |
| Selling, general and administrative | 954.34K |
| Total operating expenses | 2.84M |
| Operating loss | -2.84M |
| Foreign exchange gain (loss) | -103 |
| Investment and other income | 7.07K |
| Gain on change in fair value of warrant liability | |
| Loss on liquidation of foreign entity | |
| Gain on sale of marketable investments, net | |
| Interest expense | -23.36K |
| Net income (loss) | -3.27M |
| Basic | 27.52M |
| Diluted | 27.52M |
| Basic income (loss) per common share | -0.12 |
| Diluted income (loss) per common share | -0.12 |